<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_HKUST_Project_Background"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:HKUST/Project/Background">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:HKUST/Project/Background&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:HKUST/Project/Background&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:HKUST/Project/Background&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:HKUST/Project/Background" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:HKUST/Project/Background</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2010.igem.org</H3><P><TITLE>Team: HKUST</TITLE></P><DIV id="body_content_project"><DIV id="sidebar"><UL><LI><A href="https://2010.igem.org/Team:HKUST">HOME</A></LI><LI><A href="https://2010.igem.org/Team:HKUST/Team">Here we are!</A></LI><LI><A href="https://2010.igem.org/Team:HKUST/Accomplishment">Accomplishment</A></LI><LI><A>Project</A></LI><LI class="project"><A href="https://2010.igem.org/Team:HKUST/Project">Abstract</A></LI><LI class="project"><A href="https://2010.igem.org/Team:HKUST/Project/Background">Background</A></LI><LI class="project"><A href="https://2010.igem.org/Team:HKUST/Project/Experiment Design">Experimental Design</A></LI><LI class="project"><A href="https://2010.igem.org/Team:HKUST/Project/Results and Discussion">Experimental Results</A></LI><LI class="project"><A href="https://2010.igem.org/Team:HKUST/Project/Materials and Methods">Materials and Methods</A></LI><LI class="project"><A href="https://2010.igem.org/Team:HKUST/future_work">Future Work</A></LI><LI><A href="https://2010.igem.org/Team:HKUST/biobrick">BioBricks</A></LI><LI><A href="https://2010.igem.org/Team:HKUST/Human_Practice">Human Pratice</A></LI><LI><A href="https://2010.igem.org/Team:HKUST/Notebook">Lab Notebook</A></LI><LI><A href="https://2010.igem.org/Team:HKUST/attribution">Contributions</A></LI><LI><A href="https://2010.igem.org/Team:HKUST/Acknowledgement">Acknowledgement</A></LI><LI><A href="https://2010.igem.org/Team:HKUST/Safety">Biosafety</A></LI></UL></DIV><DIV id="module_1"><P class="h1"><B>Background</B></P><P class="h2"><B><A href="#1">1. <EM>Staphylococcus aureus</EM></A><A href="#2">2. Two-Component Signaling System (TCS)</A><A href="#3">3. <EM>Staphylococcus aureus</EM> virulence regulating mechanism: AgrBDCA</A><A href="#4">4. <EM>Lactobacillus plantarum</EM> WCFS1 quorum sensing system: PlnABCD</A><A href="#5">5. RNAIII inhibiting peptide (RIP) of <EM>Staphylococcus aureus</EM></A><A href="#6">6. References</A></B></P><P class="h2"><B>1. <EM>Staphylococcus aureus</EM></B></P><P class="content"><EM>Staphylococcus aureus</EM> is a facultatively anaerobic,  gram-positive coccus which forms large round yellow colonies when grown on agar  plate [<A href="#r1">1</A>]. It was reported that approximately 20% of human population are  long-term carriers of at least one <EM>S. aureus</EM>strain [<A href="#r2">2</A>]. As a versatile and potential dangerous pathogen, <EM>S. aureus</EM> can cause a wide range of  diseases varying from skin flora infections to invasive infections such as  sepsis syndrome [<A href="#r1">1</A>, <A href="#r3">3</A>]. Many of these diseases are associated with regulation  factors involved in toxin synthesis in <EM>S.  aureus</EM>. These bacterial regulation factors play critical roles in virulence  production; the strains that are defective in producing toxin regulation  factors always show weakened virulence [<A href="#r4">4</A>]. The aforementioned information  suggests a novel therapy, which involves the inhibition of toxin regulation factors,  for diseases caused by <EM>S. aureus</EM>.</P><P class="h2"><B>2. Two-Component Signaling System (TCS)</B></P><P class="content">In many bacterial species, Two-Component Signaling System (TCS) plays a prominent role in quorum sensing. A classical TCS consists of a transmembrane receptor, which is a histidine protein kinase (HPK), and a cytoplasmic response regulator (RR) [<A href="#r5">5</A>]. When bound by autoinducing peptides (AIP), the transmembrane receptor HPK passes a phosphate group to the downstream cytoplasmic response regulator RR. The cytoplasmic response regulator will then up-regulates or down-regulates various virulence and bacteriocin productions under specific situations [<A href="#r6">6</A>]. Figure 1 below illustrates the components and transduction pathways of a typical two-component signaling system:
</P><P class="h2"><B>3. <EM>Staphylococcus aureus</EM> virulence regulating mechanism: AgrBDCA</B></P><P class="content">A chromosomal locus <EM>agr</EM> system in <EM>S. aureus</EM> consists of two  transcription units RNA II and RNA III; they are responsible for self-regulation  and effect response respectively [<A href="#r7">7</A>, <A href="#r8">8</A>]. RNA II, driven by P2 promoter, is a polycistronic mRNA  containing four open reading frames: <EM>agrB</EM>, <EM>agrD</EM>, <EM>agrC</EM> and <EM>agrA</EM>, and are responsible for <EM>agr</EM> quorum sensing in <EM>S. aureus</EM> [<A href="#r9">9</A>]. AgrB is an integral membrane protein; AgrD is a pro-peptide secreted  with the aid of AgrB, yielding an octapeptide pheromone autoinducing peptide  (AIP); AgrC and AgrA compose a bacterial two-component signal transduction system, in which AgrC, a membrane associated protein, serves as a receptor and  AgrA acts as a DNA-binding response regulator[<A href="#r10">10</A>,<A href="#r11">11</A>, <A href="#r12">12</A>]. Once the transmembrane receptor domain of AgrC  is bound by AIP, its cytoplasmic HPK domain will pass a phosphate group  downwards to AgrA, the response regulator. AgrA functions as a transcription  factor and activates the two promoters P2 and P3 [<A href="#r13">13</A>, <A href="#r14">14</A>]. RNA III, driven by P3 promoter, acts as  a regulatory factor to activate numerous toxin production genes and encode for  β-hemolysin [<A href="#r15">15</A>].Figure  2 below shows the pathways involved in <EM>S.  aureus</EM> AgrBDCA system:
</P><P class="content">It  has been reported that there are altogether 4 types of <EM>agr</EM> loci; each type of <EM>agr</EM> locus encodes AgrC and corresponding AIP slightly different from others. AgrC  is only activated by AIP belonging to the same group and is usually inhibited  by AIP from other groups [<A href="#r16">16</A>]. Different groups of AgrC and their corresponding  AIPs are highly involved in various human diseases or infections. For example,  food poisoning caused by staphylococcal enterotoxins is usually associated with <EM>agr</EM> group I and <EM>agr</EM> group II <EM>S. aureus</EM>;  toxic shock syndrome toxin 1 (TSST-1), which results in high fever, low blood  pressure and malaise of human, is produced by <EM>agr</EM> group III <EM>S. aureus</EM> [<A href="#r17">17</A>].</P><P class="content">The synthesis of  RNAIII is regulated by two <EM>Staphylococcal </EM>quorum sensing systems SQS 1 and SQS 2. SQS 1 consists of a 277-amino-acid  RNAIII-activating protein (RAP) and a 167-amino-acid target of  RNAIII-activating protein (TRAP) which is membrane associated [<A href="#r15">15</A>]; SQS 2  consists of molecules encoded by <EM>agr</EM> system [<A href="#r18">18</A>]. As <EM>S. aureus</EM> multiplies,  RAP is secreted. Once RAP reaches a threshold concentration, it will induce the  histidine phosphorylation of TRAP, which leads to the activation of <EM>agr</EM> system and therefore induces the  production of RNAII during the mid-exponential growth phase [<A href="#r15">15</A>]. After the  activation of <EM>agr</EM> system, phosphorylation  of AgrC is induced by secreted AIP, followed by the production of RNAIII [<A href="#r18">18</A>]. 
</P><P class="content">The characteristics  of <EM>S. aureus</EM> AgrBDCA system make it possible to build an engineered AIP sensor on the membrane of a non-pathogenic  bacterial species. The engineered AIP sensor, localized on the non-virulent  bacteria, could therefore detect the presence of AIP molecules released by <EM>S. aureus</EM>. Upon receiving this signal,  the non-virulent bacteria could be automatically induced to synthesize AIP’s  competitor, RNAIII inhibiting peptide (RIP), and hence, repress the activation  of AgrC and toxin production in <EM>S. aureus</EM>.</P><P class="h2"><B>4. <EM>Lactobacillus plantarum</EM> WCFS1 quorum sensing system: PlnABCD</B></P><P class="content">Several <EM>agr</EM>-like  quorum sensing systems in <EM>Lactobacillus  plantarum </EM>WCFS1 have been identified, among which the PlnABCD system is the  best studied [<A href="#r5">5</A>]. The PlnABCD system, similar to the AgrBDCA system, is a self-regulating  system in <EM>L. plantarum </EM>WCFS1. The  transmembrane receptor HPK PlnB, together with two response regulators PlnC and  PlnD, constitutes a two-component signaling system (TCS) in <EM>L. plantarum </EM>WCFS1. PlnA, the inducing  peptide (IP) of <EM>L. plantarum </EM>WCFS1,  activates PlnB and thereby phosphoylates PlnC or PlnD. PlnC and PlnD are  upregulator and downreuglater of plnA promoter respectively, and therefore,  would activate/suppress the transcription initiation of plnABCD. The  transcription of plnABCD is usually associated with <EM>Lactobacillus plantarum </EM>WCFS1 bacteriocin production [<A href="#r19">19</A>]. Figure 3  below shows the pathways involved in <EM>Lactobacillus  plantarum </EM>WCFS1 PlnABCD system:
</P><P class="content">Transmembrane  signal sensors of both PlnABCD and AgrBDCA systems, i.e. PlnB (of <EM>L. plantarum </EM>WCFS1) and AgrC (of<EM> S. aureus</EM>), belong to a same subgroup  of histidine protein kinases – the HPK10 subfamily. PlnB and AgrC  share a highly homologous cytoplasmic HPK domain regarding amino acid sequence,  tertiary structure and biochemical function [<A href="#r14">14</A>, <A href="#r19">19</A>]. However, the sequence of  PlnB and AgrC’s transmembrane domain are distinct from each other, probably due  to the ligand binding specificity required by their corresponding signaling  molecules. </P><P class="content">Based on the  homology between AgrBDCA and PlnABCD at the cytoplasmic HPK domain, we decided  to construct a chimeric AIP sensor in<EM> Lactobacillus</EM>.  Such a fusion receptor would link the transmembrane signal sensing domain of AgrCand the cytoplasmic HPK domain of PlnB.  By localizing such a fusion protein on <EM>Lactobacillus </EM>plasma membrane, it is hoped that <EM>Lactobacillus </EM>can successfully detect the presence of autoinducing peptides (AIPs)  produced by <EM>S. aureus</EM>. Upon the  detection of AIP molecules, the chimeric protein kinase will transduce the  signal to <EM>L. plantarum </EM>WCFS1intrinsic downstream pathways.</P><P class="h2"><B>5. RNAIII inhibiting peptide (RIP) of <EM>Staphylococcus aureus</EM></B></P><P class="content">The <EM>S. aureus</EM> RN833 is a mutant strain of  Foggi (now listed as RN831) as it no longer produces α-hemolysin. Instead,  RNAIII inhibiting peptide, an inhibitor of <EM>agr</EM> system abbreviated as RIP, was discovered and tested in 1993 [20]. Heptapeptide RIP has been  proved to be an effective inhibitor to reduce virulence and prevent infections  of <EM>S. aureus</EM> [<A href="#r18">18</A>, <A href="#r21">21</A>]. </P><P class="content">The sequence of RIP was  identified as YSPXTNF, where X can be a Cys, a Trp, or a modified amino acid  [<A href="#r18">18</A>]. It is similar to the NH2 terminal sequence of RAP IKKYKPITN  [<A href="#r22">22</A>], the natural ligand of TRAP receptor. Therefore, it is hypothesized that  RAP and RIP bind to the same receptor, TRAP [<A href="#r23">23</A>]. Through competing with RAP on  binding to TRAP and thus interfering with the activation of <EM>agr</EM> system, RIP inhibits the expression  of RNAIII and the toxin genes in <EM>S.  aureus</EM>. Based on the fact that TRAP is highly conserved among <EM>S. aureus</EM> strains, RIP is supposed to inhibit  pathogenesis of most <EM>S. aureus</EM> strains infections [<A href="#r18">18</A>]. </P><P class="content">A synthetic RIP derivative  YKPWTNF was tested for its ability to inhibit RNAIII synthesis <EM>in vitro</EM> and to prevent infection <EM>in vivo </EM>[<A href="#r23">23</A>]. The  natural RIP and its synthetic derivatives have higher binding affinity to TRAP than  RAP, and therefore would inhibit the normal pathway of TRAP by induced  by RAP [<A href="#r24">24</A>]. Researches indicated that RIP YKPWTNF can suppress  virulence of any <EM>S. aureus</EM> strain so  far tested [<A href="#r18">18</A>, <A href="#r23">23</A>]. 
</P><P class="content">A 13-residue  dermaseptin derivative DD13, identified as ALWKTLLKKVLKA, is believed to have  the ability to kill bacteria via membrane disruption. The synthetic hybrid construct  DD13-RIP derivative ALWKTLLKKVLKAYSPWTNF-CONH2 has been tested for  the ability to suppress quorum sensing of <EM>S.  aureus</EM><EM>in vitro</EM> and shows  synergistic effect comparing with single synthetic RIP derivative YKPWTNF-CONH2  [<A href="#r25">25</A>]. Hence, by functionally expressing the hybrid peptide DD13-RIP  derivative, <EM>S. aureus</EM> infections may  be inhibited through restraining quorum sensing systems. However, since the  hybrid construct is made on a DNA level, after transcription and translation, the  synthetic RIP will be in the form of ALWKTLLKKVLKAYSPWTNF-COOH other than the  synthetic one ALWKTLLKKVLKAYSPWTNF-CONH2, which may lead to an  altered efficiency.</P><P class="h1"><B>6.References:</B></P><OL class="reference"><LI>Ryan, K.J., Ray, C.G., &amp; Ahmad, N. (2004). Sherris  medical microbiology. McGraw-Hill.    <A href="javascript:history.go(-1)">Back</A></LI><LI>Kluytmans, J., van Belkum, A., &amp; Verbrugh, H. (1997).  Nasal carriage of <EM>Staphylococcus aureus</EM>: epidemiology, underlying mechanisms, and  associated risks. <EM>Clin Microbiol Rev</EM>, <EM>10</EM>(3), 505-520.     <A href="javascript:history.go(-1)">Back</A></LI><LI>Franklin, D., &amp; Lowy, F.D.  (1998). <EM>Staphylococcus aureus</EM> infections. <EM>N Engl J Med</EM>, <EM>339</EM>(27), 520-532.     <A href="javascript:history.go(-1)">Back</A></LI><LI>Kiran, M.D., Adikesavan, N.V., Cirioni, O., Giacometti, A., Silvestri, C., Scalise,  G., Ghiselli, R., Saba, V., Orlando, F., Shoham, M., &amp; Balaban, N. (2008). Discovery of a  quorum-sensing inhibitor of drug-resistant Staphylococcal infections by structure-based  virtual screening. <EM>Mol Pharmacol</EM>, <EM>73</EM>(5), 718-726.      <A href="javascript:history.go(-1)">Back</A></LI><LI>Sturme, M.H.J.,  Francke, C., Siezen, R.J., de Vos, W.M., &amp; Kleerebezem, M. (2007). Making sense of  quorum sensing in <EM>lactobacilli</EM>: a  special focus on <EM>lactobacillus plantarum  wcfs1</EM>. <EM>Microbiology</EM>, 153,  3939–3947.      <A href="javascript:history.go(-1)">Back</A></LI><LI>Kleerebezem, M.,  Quadri, L. E. N., Kuipers, O. P. &amp; De Vos, W. M.(1997). Quorum sensing  by peptide pheromones and two-componentsignal-transduction systems in  Gram-positive bacteria. <EM>Molecular  Microbiology</EM>, l24, 895–904.      <A href="javascript:history.go(-1)">Back</A></LI><LI>Morfeldt, E., Janzon, L., Arvidson, S.,  and Lofdahl, S. (1988) Cloning of a chromosomal locus (exp) which regulates the  expression of several exoprotein genes in <EM>Staphylococcus  aureus</EM>. <EM>Mol Gen Genet</EM>, 211,  435–440.      <A href="javascript:history.go(-1)">Back</A></LI><LI>Ji, G., Beavis, R.C., and Novick, R.P. (1995) Cell  density control of staphylococcal virulence mediated by an octapeptide  pheromone. <EM>Proc Natl Acad Sci USA</EM>,  92, 12055–12059.      <A href="javascript:history.go(-1)">Back</A></LI><LI>Novick,  R.P., Ross, H.F., Projan, S.J., Kornblum, J., Kreiswirth, B., &amp; Moghazeh, S. (1993). Synthesis of  Staphylococcal virulence factors is controlled by a regulatory RNA  molecule. <EM>EMBO J</EM>, <EM>12</EM>(10), 3967-3975.      <A href="javascript:history.go(-1)">Back</A></LI><LI>Koenig, R.L., Ray,  J.L., Maleki, S.J., Smeltzer, M.S.,  Hurlburt, B.K. (2004). <EM>Staphylococcus aureus</EM> AgrA binding to  the RNAIII-<EM>agr</EM> regulatory  region. <EM>J of Bacteriol</EM>, <EM>186</EM>(22), 7549-7555.      <A href="javascript:history.go(-1)">Back</A></LI><LI>Korem, M., Sheoran ,  A.S., Gov, Y., Tzipori, S., Borovok, I., &amp; Balaban, N. (2003).  Characterization of RAP, a quorum sensing activator of <EM>Staphylococcus aureus</EM>. <EM>FEMS  Microbiol Lett</EM>, <EM>223</EM>(2), 167-175.      <A href="javascript:history.go(-1)">Back</A></LI><LI>Balaban, N., Goldkorn, T., Gov, Y., Hirshberg, M., Koyfman, N., Matthews, H.R., Nhan, R.T., Singh, B., Uziel, O. (2001). Regulation of <EM>Staphylococcus aureus</EM> pathogenesis via  target of RNAIII-activating protein (TRAP). <EM>J Biol Chem</EM>, <EM>276</EM>(4),  2658-2667.     <A href="javascript:history.go(-1)">Back</A></LI><LI>Novick RP,  Projan SJ, Kornblum J, Ross HF, Ji G, et al. 1995. The agr P2 operon: an  autocatalytic sensory transduction system in taphylococcus aureus. <EM>Mol. Gen. Genet</EM>, 248, 446–58.       <A href="javascript:history.go(-1)">Back</A></LI><LI>Novick, R. P. &amp;  Geisinger, E. (2008). Quorum sensing in <EM>Staphylococci</EM><EM>. Annual Review of Genetics, 42,</EM><EM> </EM>541–64.     <A href="javascript:history.go(-1)">Back</A> </LI><LI>Gov,  Y., Borovok, I., Korem, M., Singh, V.K., Jayaswal, R.K., Wilkinson, B.J., Rich, S.M., &amp;  Balaban, N. (2004). Quorum  sensing in <EM>Staphylococci</EM> is regulated  via phosphorylation of three conserved histidine residues. <EM>J Biol Chem</EM>, <EM>279</EM>(15), 14665-14672.     <A href="javascript:history.go(-1)">Back</A> </LI><LI>Geisinger, E.,  George, E.A., Muir, T.W., &amp; Novick, R.P.(2008). Identification of ligand  specificity determinants in agrc, the <EM>staphylococcus  aureus</EM> quorum-sensing receptor . <EM>The  Journal of Biological Chemistry</EM>, 283(14), 8930–8938.     <A href="javascript:history.go(-1)">Back</A></LI><LI>Jarraud, S.,  Mougel, C., Thioulouse, J., &amp; Lina, G. (2002). Relationships between <EM>staphylococcus aureus</EM> genetic  background, virulence factors, agr groups (alleles), and human disease . <EM>Infection and Immunity</EM>, 70(2),  631–641.      <A href="javascript:history.go(-1)">Back</A></LI><LI>Gov, Y., Bitler, A.,  Dell'Acqua, G., Torres, J.V.,  &amp; Balaban, N. (2001). RNAIII inhibiting peptide (RIP), a global inhibitor of <EM>Staphylococcus aureus</EM> pathogenesis:  structure and function analysis. <EM>Peptides</EM>, <EM>22</EM>(10), 1609-1620.      <A href="javascript:history.go(-1)">Back</A></LI><LI>Johnsborg, O.,  Diep, D. B. &amp; Nes, N. F. (2003). Structural analysis of the peptide  pheromone receptor plnB, a histidine protein kinase from <EM>Lactobacillus plantarum</EM><EM>. Journal of  Bacteriology, 185</EM><EM> </EM>(23),  6913–6920.      <A href="javascript:history.go(-1)">Back</A></LI><LI>Balaban, N., &amp;  Novick, R.P. (1995). Autocrine regulation of toxin synthesis by <EM>Staphylococcus aureus</EM>. <EM>Proc Natl Acad Sci U S A</EM>, <EM>92</EM>(5), 1619-1623.        <A href="javascript:history.go(-1)">Back</A></LI><LI>Costerton JW, Montanaro L, Arciola CR. (2007). Bacterial  communications in implant infections: a target for an intelligence war.<EM> Int J  Artif Organs.</EM> 30(9):757-63.    <A href="javascript:history.go(-1)">Back</A></LI><LI>Novick, R.P., Ross,  H.F., Figueiredo, A.M.S., Abramochkin, G., Muir, T., Balaban, N., Singh, B.,  Goldkorn, T., Rasooly, A., Torres, J.V., &amp; Uziel, O. (2000). Activation and  inhibition of the Staphylococcal<EM> agr</EM> system. <EM>Science</EM>, <EM>287</EM>, 391.    <A href="javascript:history.go(-1)">Back</A> </LI><LI>Balaban, N., Collins, L.V., Cullor, J.S.,  Hume, E.B., Medina-Acosta,  E., Vieira da Motta, O., O'Callaghan, R.,  Rossitto, P.V., Shirtliff, M.E., Serafim da Silveira, L., Tarkowski, A., &amp;  Torres, J.V. (2000). Prevention  of diseases caused by <EM>Staphylococcus  aureus</EM> using the peptide RIP. <EM>Peptides</EM>, <EM>21</EM>(9), 1301-1311.    <A href="javascript:history.go(-1)">Back</A> </LI><LI>Balaban, N.,  Goldkorn, T., Nhan, R.T., Dang,  L.B., Scott, S., Ridgley, R.M., Rasooly, A., Wright, S.C., Larrick, J.W., Rasooly, R., &amp; Carlson, J.R. (1998). Autoinducer  of virulence as a target for vaccine and therapy against <EM>Staphylococcus aureus</EM>. <EM>Science</EM>, <EM>280</EM>(5362), 438-440.     <A href="javascript:history.go(-1)">Back</A></LI><LI>Balaban, N., Gov, Y., Giacometti, A., Cirioni, O., Ghiselli, R., Mocchegiani, F., Orlando, F., D'Amato, G., Saba, V., Scalise, G., Bernes, S., &amp; Mor, A. (2004). A chimeric peptide  composed of a dermaseptin derivative and an RNAIII-inhibiting peptide prevents  graft-associated infections by antibiotic-resistant <EM>Staphylococci</EM>. <EM>Antimicrob  Agents Chemother</EM>, <EM>48</EM>(7),  2544-2550.      <A href="javascript:history.go(-1)">Back</A></LI></OL></DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2010.igem.org/Team:HKUST/Project/Background">http://2010.igem.org/Team:HKUST/Project/Background</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:HKUST/Project/Background" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:HKUST/Project/Background" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:HKUST/Project/Background&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:HKUST/Project/Background&amp;oldid=132756" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2010.igem.org:Privacy_policy" title="2010.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2010.igem.org:General_disclaimer" title="2010.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>